VIANELLO, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 11.430
AS - Asia 2.078
EU - Europa 1.836
SA - Sud America 373
AF - Africa 59
OC - Oceania 7
Totale 15.783
Nazione #
US - Stati Uniti d'America 11.409
SG - Singapore 1.148
IT - Italia 637
CN - Cina 607
BR - Brasile 342
DE - Germania 222
HK - Hong Kong 202
FI - Finlandia 173
SE - Svezia 149
RU - Federazione Russa 128
PL - Polonia 120
FR - Francia 111
GB - Regno Unito 97
UA - Ucraina 52
NL - Olanda 40
CI - Costa d'Avorio 38
IN - India 37
VN - Vietnam 34
AT - Austria 23
IE - Irlanda 20
AR - Argentina 11
CA - Canada 11
RO - Romania 11
TR - Turchia 10
BE - Belgio 9
ES - Italia 8
IQ - Iraq 8
MX - Messico 8
JP - Giappone 7
CO - Colombia 6
AU - Australia 5
BD - Bangladesh 5
EC - Ecuador 5
NO - Norvegia 5
ZA - Sudafrica 5
PH - Filippine 4
PY - Paraguay 4
CH - Svizzera 3
CZ - Repubblica Ceca 3
GR - Grecia 3
HU - Ungheria 3
KR - Corea 3
LV - Lettonia 3
BG - Bulgaria 2
EG - Egitto 2
GA - Gabon 2
IL - Israele 2
KG - Kirghizistan 2
LT - Lituania 2
MA - Marocco 2
MT - Malta 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
SI - Slovenia 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
IR - Iran 1
KE - Kenya 1
LU - Lussemburgo 1
MK - Macedonia 1
ML - Mali 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
UY - Uruguay 1
VE - Venezuela 1
Totale 15.783
Città #
Fairfield 2.203
Chandler 974
Woodbridge 970
Ashburn 949
Houston 806
Seattle 758
Cambridge 740
Singapore 621
Wilmington 590
Ann Arbor 443
Santa Clara 297
Boardman 287
San Diego 255
Princeton 209
Hong Kong 199
Jacksonville 178
Medford 164
Beijing 147
Roxbury 142
Padova 140
Des Moines 112
Bytom 111
Helsinki 102
Nanjing 54
Guangzhou 46
Milan 41
Abidjan 38
Dong Ket 34
Los Angeles 31
Nuremberg 30
New York 29
London 27
Shanghai 24
Rome 23
São Paulo 23
Norwalk 21
Dublin 20
Pune 19
Changsha 18
Lappeenranta 18
Falkenstein 16
Ogden 16
Shenyang 16
Munich 15
Nanchang 15
Chicago 14
Dallas 14
Vicenza 14
Verona 13
Vienna 13
Villafranca Padovana 13
Washington 13
Hebei 12
Kilburn 11
Tianjin 11
Belo Horizonte 10
Kunming 10
Bologna 9
Brasília 9
Brussels 9
Frankfurt am Main 9
Kharkiv 9
Paris 9
Venice 9
Acton 8
Jiaxing 8
Jinan 8
Turku 8
Zhengzhou 8
Borås 7
Lauterbourg 7
Mogliano Veneto 7
Rio de Janeiro 7
Hefei 6
Portsmouth 6
Prescot 6
Salt Lake City 6
Salvador 6
Amsterdam 5
Baghdad 5
Contagem 5
Curitiba 5
Dongguan 5
Hangzhou 5
San Mateo 5
Sassuolo 5
Tokyo 5
Bucharest 4
Buenos Aires 4
Campinas 4
Duncan 4
Edinburgh 4
Fuzhou 4
Granada 4
Guarulhos 4
Gubbio 4
Islington 4
Istanbul 4
Lanzhou 4
Las Vegas 4
Totale 12.377
Nome #
Surfactant disaturated-phosphatidylcholine kinetics in acute respiratory distress syndrome by stable isotopes and a two compartment model 166
Cardiomyopathy in patients with POMT1-related congenital and limb-girdle muscular dystrophy. 147
Retrospective Analysis of a Modified Organizational Model to Guarantee CT Workflow during the COVID-19 Outbreak in the Tertiary Hospital of Padova, Italy 144
High-flow nasal cannula oxygen therapy to treat acute respiratory failure in patients with acute exacerbation of idiopathic pulmonary fibrosis 142
The mutual association between dyspnea and depressive symptoms in older adults: a 4-year prospective study 139
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: the Multicenter Italian CORIST Study 139
Hyperglycemia, glucocorticoid therapy, and outcome of COVID-19 136
A chart of failure risk for noninvasive ventilation in patients with COPD exacerbation 134
Oral appliances for the treatment of obstructive sleep apnea in patients with low C-PAP compliance: A long-term case series 134
Vaccination recommendations for patients with neuromuscular disease 133
Acute colonic distension in a patient with severe muscular dystrophy receiving non-invasive positive pressure ventilation 133
Body composition and resting energy expenditure in elderly male patients with chronic obstructive pulmonary disease 131
Effect of a passive exhalation port on tracheostomy ventilation in amyotrophic lateral sclerosis patients: A randomized controlled trial 129
Exposure to DPP-4 inhibitors and COVID-19 among people with type 2 diabetes. A case-control study 129
The Association Between Bone Mineral Density and Airflow Limitation in a Cohort of Fit Elderly Women 128
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 127
Survival and quality of life after tracheostomy for acute respiratory failure in patients with amyotrophic lateral sclerosis 126
Diagnosis of glycogenosis type II 126
Enzyme replacement therapy improves respiratory outcomes in patients with late-onset type II glycogenosis and high ventilator dependency 124
Acute colonic pseudo-obstruction causing Acute Respiratory Failure in Duchenne Muscular Dystrophy 123
Tracheoinnominate fistula in a Duchenne muscular dystrophy patient: Successful management with an endovascular stent 122
Pirfenidone improves the survival of patients with idiopathic pulmonary fibrosis hospitalized for acute exacerbation 121
Cardiopulmonary exercise testing responses to different external portable drivers in a patient with a CardioWest Total Artificial Heart 119
A mobile app for patients with Pompe disease and its possible clinical applications 119
Spontaneous pneumomediastinum complicating severe acute asthma exacerbation in adult patients 119
Genetic modifiers of respiratory function in Duchenne muscular dystrophy 118
Pneumothorax associated with long-term non-invasive positive pressure ventilation in Duchenne muscular dystrophy 116
An untreatable dyspnoea: more defendants under investigation 115
MYH7 gene mutation in myosin storage myopathy and scapulo-peroneal myopathy 113
The successful management of a patient with exacerbation of non-cystic fibrosis bronchiectasis and bilateral fibrothorax using a venovenous extracorporeal carbon dioxide removal system 113
Comparison of two methods for weaning patients with chronic obstructive pulmonary disease requiring mechanical ventilation for more than 15 days 113
COVID-19 challenge: proactive management of a Tertiary University Hospital in Veneto Region, Italy 113
Nasal and oral snoring endoscopy: novel and promising diagnostic tools in OSAS patients 112
Prevention of extubation failure in high-risk patients with neuromuscular disease 111
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) 110
Chronic obstructive pulmonary disease (COPD) in elderly subjects: impact on functional status and quality of life 108
Maximal inspiratory and expiratory pressure measurement in tracheotomised patients 108
Respiratory outcomes of patients with amyotrophic lateral sclerosis: An italian nationwide survey 107
Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration 107
Complications of non-invasive ventilation techniques: A comprehensive qualitative review of randomized trials 106
Assessment of physiologic variables and subjective comfort under different levels of pressure support ventilation 106
Cough assistance to clear lungs of ALS patients with severe bulbar dysfunction: Not a good idea! 105
Deep neck abscesses due to Acinetobacter baumanii infection. 104
Pneumothorax associated with long-term non-invasive positive pressure ventilation in Duchenne muscular dystrophy. 104
Management and treatment of glycogenosis type II 103
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study 103
Clinical and pulmonary function markers of respiratory exacerbation risk in subjects with quadriplegic cerebral palsy 102
Prevalence of severe asthma according to the drug regulatory agency perspective: An Italian experience 102
Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia 102
Noninvasive positive pressure ventilation in the management of acute respiratory failure due to osteogenesis imperfecta 101
Assessment of physiologic variables and subjective comfort under different levels of pressure support ventilation 101
Cardiac and respiratory involvement in advanced stage Duchenne muscular dystrophy. 99
RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies 99
Omalizumab management beyond clinical trials: The added value of a network model 99
Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity 99
Costs of the COPD. Differences between intensive care unit and respiratory intermediate care unit 98
Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience 97
Tracheostomy tubes are not needed for Duchenne muscular dystrophy [3] 96
Low adherence to inhaled corticosteroids/long-acting β2-agonists and biologic treatment in severe asthmatics 96
Tracheostomy ventilation in ALS: A Japanese bias 95
High-flow nasal cannula oxygen therapy to treat patients with hypoxemic acute respiratory failure consequent to SARS-CoV-2 infection 95
Effect of induction chemotherapy on lung function and exercise capacity in patients affected by malignant pleural mesothelioma 94
Noninvasive ventilation in the event of acute respiratory failure in patients with idiopathic pulmonary fibrosis 94
Hospital at home" for neuromuscular disease patients with respiratory tract infection: a pilot study. 94
Thunderstorm asthma: A critical appraisal based on clinical practice 94
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy 94
Chest infections in young neuromuscular patients: The critical importance of preserving Vital Capacity 94
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study 94
Sleep-related adductor Laryngeal dystonia causing sleep apnea: A sleep-related breathing disorder diagnosed with sleep endoscopy and treated with botulinum toxin. 93
Effects of a structured educational intervention in moderate-to-severe elderly asthmatic subjects 93
Disentangling the association of hydroxychloroquine treatment with mortality in covid-19 hospitalized patients through hierarchical clustering 93
Chronic obstructive pulmonary disease (COPD) in elderly subjects: impact on functional status and quality of life 92
Trends and determinants of Emergency Room admissions for asthma: A retrospective evaluation in Northeast Italy 92
Sleep-related adductor Laryngeal dystonia causing sleep apnea: A sleep-related breathing disorder diagnosed with sleep endoscopy and treated with botulinum toxin 91
Noninvasive ventilation in patients with idiopathic pulmonary fibrosis is not a futile intervention! 90
Gastrostomy in amyotrophic lateral sclerosis: Effects of non-invasive ventilation 90
Lung Ultrasound Patterns and Clinical-Laboratory Correlates during COVID-19 Pneumonia: A Retrospective Study from North East Italy 90
Health and social impacts of COPD and the problem of under-diagnosis 89
Last 3 months of life in home-ventilated patients: The family perception 89
Epidemiology and clinical course of severe acute respiratory syndrome coronavirus 2 infection in cancer patients in the Veneto Oncology Network: The Rete Oncologica Veneta covID19 study 88
Outcomes of COVID-19 patients intubated after failure of non-invasive ventilation: a multicenter observational study 88
Long-term nasal intermittent positive pressure ventilation in advanced Duchenne's muscular dystrophy 87
Place of death in patients with amyotrophic lateral sclerosis 87
Non-invasive ventilatory approach to treatment of acute respiratory failure in neuromuscular disorders. A comparison with endotracheal intubation 87
Benralizumab as a glucocorticoid-sparing treatment option for severe asthma in eosinophilic granulomatosis with polyangiitis 87
Non-Invasive Ventilation for Acute Respiratory Failure in Duchenne Muscular Dystrophy Patients 87
Home mechanical ventilation patients: a retrospective survey to identify level of burden in real life 85
Mechanical Insufflation-Exsufflation Improves Outcomes for Neuromuscular Disease Patients with Respiratory Tract Infections. 84
Cardiopulmonary exercise testing in patients with moderate-severe obesity: a clinical evaluation tool for OSA? 83
The role of respiratory management of Pompe disease 82
Surfactant disaturated-phosphatidylcholine turnover and pool size in humans with ARDS 81
Fatal asthma; is it still an epidemic? 81
Mechanical insufflation-exsufflation improves outcomes for neuromuscular disease patients with respiratory tract infections 80
Therapeutic Value and Innovation of a Drug and Criteria for Evaluation: A Multidisciplinary Experience in the Veneto Region 80
Reduced muscle mass as predictor of intensive care unit hospitalization in COVID-19 patients 80
Reduction in respiratory exacerbation rate in patients with severe bilateral cerebral palsy following daily PEP-mask therapy: a retrospective study 80
Extubation of patients with neuromuscular weakness: A routine step or a challenging procedure? 79
Characteristics and treatment regimens across ERS SHARP severe asthma registries 79
1st Italian SMA Family Association Consensus Meeting: Management and recommendations for respiratory involvement in spinal muscular atrophy (SMA) types I-III, Rome, Italy, 30-31 January 2015 78
QOLEC2: a randomized controlled trial on nutritional and respiratory counseling after esophagectomy for cancer 78
Totale 10.467
Categoria #
all - tutte 74.135
article - articoli 70.505
book - libri 99
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.114
Totale 145.853


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020312 0 0 0 0 0 0 0 0 0 0 169 143
2020/20212.332 111 227 154 301 90 80 48 188 322 220 273 318
2021/20223.002 386 141 266 239 80 192 78 500 159 104 167 690
2022/20231.898 384 204 40 236 298 225 15 136 225 16 98 21
2023/20241.260 44 163 103 121 68 190 112 66 100 41 126 126
2024/20253.495 21 301 189 172 611 161 291 420 484 287 558 0
Totale 16.171